治疗患有牛皮关节炎和并发性炎症性肠病的患者的实际考虑
Adam S Mayer1, Ethan Craig2, Alyssa Parian3
1Division of Rheumatology, University of Pennsylvania, 3400 Spruce Street, 5 White Building, Philadelphia, PA 19104, USA; Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia.
Rheumatic diseases clinics of North America
|July 18, 2025
概括
炎症性肠病经常发生在牛皮和牛皮性关节炎. 最佳的治疗需要仔细考虑患者的这些相互关联的疾病.
科学领域:
- 皮肤病学和胃肠病学
- 伴发病性研究 研究.
背景情况:
- 牛皮和牛皮性关节炎是常见的炎症性皮肤和关节疾病.
- 炎症性肠病 (IBD) 在患有牛皮和牛皮性关节炎的患者中经常同时发生.
- 在这些患者中治疗IBD带来了独特的治疗挑战.
研究的目的:
- 突出IBD作为牛皮和牛皮性关节炎患者的并发症的重要性.
- 概述这些患者群体的最佳管理的关键考虑因素.
主要方法:
- 关于IBD与牛皮和牛皮性关节炎的并发症现有文献的综述.
- 分析治疗策略和患者管理指南.
主要成果:
- IBD影响了大量的牛皮和牛皮性关节炎患者.
- 治疗决策必须考虑到皮肤病,风湿病和胃肠道症状之间的相互作用.
结论:
- 综合护理方法对于有效管理患有牛皮/牛皮关节炎和IBD的患者至关重要.
- 需要进一步的研究来优化这种复杂的患者群体的治疗方案.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
196
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
196
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
424
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
424
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Inflammatory Bowel Disease V: Surgical Management
219
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
219
Drugs for Treatment of Ulcerative Colitis in IBD
239
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
239


